CLINICAL_TRIALS
trial_result
· 2012-01-04
Clinical Trial Update: A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension [Phase 3]
Summary
Phase 3 safety and tolerability study of azilsartan medoxomil in adults with essential hypertension has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-01-04